• Health Economics And Outcomes Research
    Health Economics And Outcomes Research - We support bio-pharma companies with real world evidence
    and economic modeling to maximize product access and value
We support bio-pharma companies with real world evidence
and economic modeling to maximize product access and value

Health Economics and Outcomes Research

  • SmartAnalyst utilizes deep disease and domain knowledge to design and deliver successful projects for our clients.
  • We take a holistic approach to Market Access, with the ability to combine patient, payor, and physician insights and work with our clients to develop economic evidence to demonstrate the value of their products.
  • We have developed and utilized innovative methodologies, such as dynamic disease modeling to forecast epidemiology of complex diseases.
Health Economics and Outcomes Research
The SmartAnalyst Difference:
  • Domain expertise in a variety of therapeutic areas, including complex areas such as oncology
  • Data agnostic - ability to employ leading retrospective patient level databases across the globe
  • Flexibility and focus on the client experience - a collaborative working relationship
  • Extensive track record of success with a highly skilled research team
Our capabilities in Health Economics Modeling include:
  • Longitudinal Data Analysis
  • Cost-effectiveness Analysis
  • Risk Sharing Analysis
  • Budget Impact Models
  • Comparative Effectiveness Models
Our capabilities in Health Economics Modeling
Download Recent Publications
NEWS

Our recent publications 

Poster Presentation at ISPOR 23rd  Annual International Conference, May 19-23, 2018, Baltimore, US

Budget Impact Analyses: Inconsistency and bias in choice of reporting measures - Ravi Potluri, Sandip Ranjan, Aakershit Kumar, Mandeep Raj, Hitesh Bhandari

2018 ASCO Annual Meeting, June 1-5, 2018, Chicago, IL, USA

Progression-free Survival as Surrogate Endpoint for Overall Survival in NSCLC Trials of Anti PD-1 and Anti PD-L1 Agents and the Impact of Line of Treatment - Anandaroop Dasgupta, Nidhi Dhingra, Tom Stinchcombe, Jaideep V Thottassery

 23rd Congress of European Hematology Association (EHA), June 14-17, 2018, Stockholm, Sweden, Europe

Our abstract has been accepted for publication in the Abstract Book

Quadrant Analysis of Drug Approval and Emerging Treatment Trends in Chronic Lymphocytic Leukemia – A Retrospective Study on Pivotal Clinical Trials - Maneesha Chhikara, Debasish Mazumder, Rohit Tyagi

Our forthcoming publications   

ISPOR - Asia Pacific 2018, Sept. 8-11, 2018, Tokyo

  •  Review of real-world databases in Japan and South Korea that could be used to inform healthcare resource use and cost inputs for health economic studies - Mazumder D, Bhandari H, Ranjan S, LoPresti M, Smulders M

  • The impact of the cost of existing treatment on the results of cost-effectiveness analysis studies for Japan -  LoPresti M, Mazumder D, Bhandari H, Ranjan S, Smulders M

      



GLOBAL HEADQUARTERS
(New York, USA)

9 East 38th Street, 8th Floor,
New York 10016
Tel.: (212) 331-0010
Fax: (212) 331-0011
Fax: (866) 256-9402

EUROPE
(London, UK)

12 Hammersmith Grove,
London, W6 7AP
Mobile: +44-(0)-752-163-8242
Mobile: +44 (0) 7903 070071

ASIA PACIFIC
(Gurgaon, INDIA)

14th Floor, Tower D, Cyber Green,
DLF City Phase-III,
Gurgaon 122002, Haryana, India
Tel.: 91-124-4313800,
91-124-4147900, 91-124-4147910-13
Fax: 91-124-4313899

Latest SMARTOncology Newsletter

click here to download

Subscribe

Latest SMARTImmunology Newsletter

click here to download